E2F3 Transcription Factor

"E2F3 Transcription Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An E2F transcription factor that interacts directly with RETINOBLASTOMA PROTEIN and CYCLIN A. E2F3 regulates GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis.

Descriptor ID

D050699

MeSH Number(s)

D12.776.930.311.750

Concept/Terms

E2F3 Transcription Factor

E2F3b Transcription Factor

E2F3a Transcription Factor

Below are MeSH descriptors whose meaning is more general than "E2F3 Transcription Factor".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Transcription Factors [D12.776.930]
E2F Transcription Factors [D12.776.930.311]
E2F3 Transcription Factor [D12.776.930.311.750]

Below are MeSH descriptors whose meaning is related to "E2F3 Transcription Factor".

Below are MeSH descriptors whose meaning is more specific than "E2F3 Transcription Factor".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "E2F3 Transcription Factor" by people in Harvard Catalyst Profiles by year, and whether "E2F3 Transcription Factor" was a major or minor topic of these publication.

Bar chart showing 26 publications over 17 distinct years, with a maximum of 3 publications in 1994 and 2001

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	3	3
1995	0	2	2
1996	0	1	1
2000	0	1	1
2001	0	3	3
2002	0	2	2
2003	0	1	1
2004	0	1	1
2007	1	0	1
2008	2	0	2
2010	1	1	2
2013	0	1	1
2014	0	2	2
2015	0	1	1
2016	0	1	1
2019	1	0	1
2020	1	0	1

Below are the most recent publications written about "E2F3 Transcription Factor" by people in Profiles.

Involvement of the lncRNA AFAP1-AS1/microRNA-195/E2F3 axis in proliferation and migration of enteric neural crest stem cells of Hirschsprung's disease. Exp Physiol. 2020 11; 105(11):1939-1949.

View in: PubMed
Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC. JCI Insight. 2019 04 04; 4(7).

View in: PubMed
Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model. Clin Cancer Res. 2017 Jan 15; 23(2):430-440.

View in: PubMed
DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors. BMC Cancer. 2015 Apr 09; 15:242.

View in: PubMed
Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression. Oncotarget. 2014 Oct 30; 5(20):9594-608.

View in: PubMed
Global epigenetic regulation of microRNAs in multiple myeloma. PLoS One. 2014; 9(10):e110973.

View in: PubMed
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer. J Clin Oncol. 2013 Sep 01; 31(25):3133-40.

View in: PubMed
miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer. Cell Death Dis. 2013 Jun 06; 4:e659.

View in: PubMed
Exploration of potential ligands against cancer-causing transcription factor E2F3. Pak J Pharm Sci. 2012 Oct; 25(4):793-801.

View in: PubMed
C/EBPa regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood. 2010 Dec 16; 116(25):5638-49.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Mol Cell Biol
Oncogene
Proc Natl Acad Sci U S A
PLoS Biol
Pak J Pharm Sci
JCI Insight
Exp Physiol
Cell Cycle
Blood
Genes Dev